Stay updated on Vibecotamab in MRD+ AML/MDS Clinical Trial

Sign up to get notified when there's something new on the Vibecotamab in MRD+ AML/MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vibecotamab in MRD+ AML/MDS Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The new screenshot shows minor layout adjustments on the Record History page, with no changes to study data, statuses, or version history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T21:08:36.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    New 2025-10-27 update adds the Study Status entry to the record history; the total versions now show 16, and an older entry from 2025-06-03 was removed.
    Difference
    0.4%
    Check dated 2025-10-27T19:12:26.000Z thumbnail image
  3. Check
    33 days ago
    Change Detected
    Summary
    New operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.
    Difference
    12%
    Check dated 2025-10-06T05:30:58.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-29T03:03:46.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed. No other core content, pricing, or availability changes were detected.
    Difference
    0.7%
    Check dated 2025-09-14T19:13:34.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.7%
    Check dated 2025-09-07T15:37:16.000Z thumbnail image

Stay in the know with updates to Vibecotamab in MRD+ AML/MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vibecotamab in MRD+ AML/MDS Clinical Trial page.